Showing 441 - 460 results of 867 for search '(( b large decrease ) OR ( ct ((((values decrease) OR (largest decrease))) OR (larger decrease)) ))', query time: 0.56s Refine Results
  1. 441

    Table 3_Interaction with IGF1 overrides ANXA2-mediated anti-inflammatory functions of IGFBP5 in vivo.xlsx by Yan Fan (575147)

    Published 2025
    “…IGFBP5 decreased in ALI mice’s blood, while its supplement exacerbated inflammation. …”
  2. 442

    Table 1_Interaction with IGF1 overrides ANXA2-mediated anti-inflammatory functions of IGFBP5 in vivo.docx by Yan Fan (575147)

    Published 2025
    “…IGFBP5 decreased in ALI mice’s blood, while its supplement exacerbated inflammation. …”
  3. 443

    Table 2_Interaction with IGF1 overrides ANXA2-mediated anti-inflammatory functions of IGFBP5 in vivo.xlsx by Yan Fan (575147)

    Published 2025
    “…IGFBP5 decreased in ALI mice’s blood, while its supplement exacerbated inflammation. …”
  4. 444
  5. 445
  6. 446
  7. 447
  8. 448
  9. 449
  10. 450
  11. 451

    Characterising the i-band variability of YSOs over six orders of magnitude in timescale (dataset) by D Sergison (21909218)

    Published 2025
    “…We present an i-band photometric study of over 800 young stellar objects in the OB association Cep OB3b, which samples timescales from 1 minute to ten years. …”
  12. 452
  13. 453
  14. 454
  15. 455
  16. 456
  17. 457
  18. 458

    Image 6_Tumor-associated bacteria activate PRDX1-driven glycolysis to promote immune evasion and PD-1 antibody resistance in hepatocellular carcinoma.jpeg by Heng Zhang (320479)

    Published 2025
    “…In vivo, bacterial infection decreased the antitumor efficacy of PD-1 blockade by 43% (tumor volume vs. control; p = 0.008), an effect that was reversed upon PRDX1 inhibition.…”
  19. 459

    Image 5_Tumor-associated bacteria activate PRDX1-driven glycolysis to promote immune evasion and PD-1 antibody resistance in hepatocellular carcinoma.jpeg by Heng Zhang (320479)

    Published 2025
    “…In vivo, bacterial infection decreased the antitumor efficacy of PD-1 blockade by 43% (tumor volume vs. control; p = 0.008), an effect that was reversed upon PRDX1 inhibition.…”
  20. 460

    Image 1_Tumor-associated bacteria activate PRDX1-driven glycolysis to promote immune evasion and PD-1 antibody resistance in hepatocellular carcinoma.jpeg by Heng Zhang (320479)

    Published 2025
    “…In vivo, bacterial infection decreased the antitumor efficacy of PD-1 blockade by 43% (tumor volume vs. control; p = 0.008), an effect that was reversed upon PRDX1 inhibition.…”